Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data
Crossref DOI link: https://doi.org/10.1007/s00417-017-3613-1
Published Online: 2017-02-18
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chatziralli, Irini
Theodossiadis, George
Moschos, Marilita M.
Mitropoulos, Panagiotis
Theodossiadis, Panagiotis
License valid from 2017-02-18